Related Experiment Video
Updated: Jun 2, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Oxidative stress and diabetic kidney disease
1Harvard Medical School, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA. robert.stanton@joslin.harvard.edu
Abstract:
The number of people with diabetic kidney disease continues to increase worldwide despite current treatments. Of the pathophysiologic mechanisms that have been identified in the development and progression of diabetic nephropathy, oxidative stress (more accurately described as increased levels of reactive oxygen species; ROS) is of major importance. The increase in ROS is due to both increased production and to decreased and/or inadequate antioxidant function. To date, human clinical trials with antioxidants have not been shown to be effective. This is likely due, at least in part, to the lack of specificity of current agents. Recent research has determined both major sources of high glucose-induced cellular ROS production as well as high glucose-induced changes in antioxidant function. Treatments targeted at one or more of the specific diabetes-induced alterations in the regulation of ROS levels will likely lead to effective treatments that prevent the development and progression of diabetic kidney disease.
Insights
Diabetic kidney disease is rising globally. Targeting specific causes of increased reactive oxygen species (ROS) may lead to effective treatments, unlike general antioxidants.
Area of Science:
- Nephrology
- Endocrinology
- Oxidative Stress Research
Background:
- Diabetic kidney disease (DKD) prevalence is increasing worldwide, posing a significant health challenge.
- Oxidative stress, characterized by elevated reactive oxygen species (ROS), is a key factor in DKD development and progression.
- Current antioxidant therapies have shown limited efficacy in human clinical trials, likely due to a lack of specificity.
Purpose of the Study:
- To investigate the specific mechanisms of high glucose-induced ROS production in diabetic nephropathy.
- To identify high glucose-induced alterations in antioxidant function relevant to DKD.
- To explore targeted therapeutic strategies for managing ROS dysregulation in DKD.
Main Methods:
- Analysis of cellular ROS production under high glucose conditions.
- Assessment of antioxidant enzyme function in the context of diabetes.
- Review of existing literature on antioxidant interventions in DKD.
Main Results:
- Identified major cellular sources of ROS production stimulated by high glucose.
- Characterized specific changes in antioxidant defense mechanisms under diabetic conditions.
- Highlighted the ineffectiveness of non-specific antioxidants in clinical trials for DKD.
Conclusions:
- Targeting specific pathways of ROS dysregulation in diabetes offers a promising therapeutic avenue.
- Developing treatments that address the precise mechanisms of ROS imbalance is crucial for preventing DKD progression.
- Future research should focus on precise interventions rather than broad antioxidant administration for effective DKD management.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Diabetic Neuropathy
Diabetic Retinopathy
Diabetic Ketoacidosis ll: Pathophysiology
Psychoneuroimmunology: Diabetes and Cancer
